Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001867 · ClinicalTrials.gov registry record

Effect of Pregnancy on Uveitis

A clinical trial, sponsored by National Eye Institute (NEI).

Completed
Registry status
10
Enrollment target

NCT00001867 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001867 has completed, sponsored by National Eye Institute (NEI).

COMPLETED
Registry status
10 participants
Enrollment target

Study Summary

The purpose of this study is to gain information about the course of uveitis (a type of eye inflammation) during pregnancy and the postpartum period (six months after delivery). Some reports have indicated the condition may improve or disappear without treatment during pregnancy and recur postpartum, requiring treatment. No systematic studies have been done, however, to examine a link between pregnancy and disease suppression. All medicines for uveitis have side effects-particularly for pregnant women, their unborn babies, and breast-feeding mothers. The information gained may help guide treatment decisions for these patients in the future. Women who are between 2 and 20 weeks pregnant and have had uveitis within 2 years of becoming pregnant will be followed monthly with an eye examination and blood tests until six months after giving birth. The eye examination will include dilation of the pupils to look at the back of the eye. Photos of the eye will be taken to record changes that occur due to uveitis. The blood tests will assess immune function and try to determine whether levels of hormones and cytokines are related to uveitis disease activity. Patients who develop an inflammation and significant vision loss may require treatment, possibly with eye drops or injections near the eye. Treatment will be decided in consultation with the patient's obstetrician.

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 1999-09
Est. Completion 2000-09

Sponsor

National Eye Institute (NEI)

221 total trials

What the Registry Record Tells You About NCT00001867

The ClinicalTrials.gov registry entry for NCT00001867 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00001867 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00001867 about?

NCT00001867 is a clinical study titled "Effect of Pregnancy on Uveitis". The purpose of this study is to gain information about the course of uveitis (a type of eye inflammation) during pregnancy and the postpartum period (six months after delivery). Some reports have indicated the condition may improve or disappear without treatment during pregnancy and recur postpartum...

What is the current status of trial NCT00001867?

This trial is currently completed. The enrollment target is 10 participants. The study started on 1999-09. Estimated completion is 2000-09.

Who is sponsoring clinical trial NCT00001867?

This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.